A drug known as erenumab may be able to help sufferers of hard-to-treat migraines, researchers have found. The preliminary study on the new treatment was released on April 17 and will be presented at the American Academy of Neurology’s 70th Annual Meeting in Los Angeles. Characterized by the frequency of attacks (at least 5, which can…